2,088 VIA tests in 2022: 10.72% positive; a “see and treat” protocol proved feasible and well accepted.
Objective: To evaluate the prevalence of CIN among VIA-positive cases and the performance of the clinic for colposcopic management of CIN.
Materials and methods: A retrospective observational study at RpMCH, January–December 2022, using the colposcopy clinic register.
Result: 2,088 VIA tests were done; 224 (10.72%) were positive. Colposcopy was done in 512 cases: 130 (25.3%) had low-grade lesions (CIN I) and 7 (1.36%) high-grade lesions (CIN II–III). Treatment was given in 117 (22.8%) cases: thermocoagulation (109) and LEEP (8).
Conclusion: The “see and treat” protocol is well accepted, feasible and useful in Bangladesh.
Published in the department’s Annual Report, July 2024 to June 2025. Download the full report
